End, aren't you the one who posted yesterday stating that a JAK2 competitor for MF treatment has been approved for the FTD by the FDA?!!!
I AM investing in ACTC and find it to have a dynamic management unlike at Geron!!! It has Lanza, the inventor, on board whereas Geron has no such person on board. Besides it's not just a one-product company. The retina-treatment RPE cells have localized effect and do not go into main blood stream to be seriously concerned about side effects. The market for the treatment is huge compared to that for the MF treatment by Imetelstat. Thus, the company should do well. The company's litigation issues have been resolved and now the management has to look for funding (for which they already have one in their fold). The other advantage is that RPE treatment must see the FDA license much faster than anticipated at present for Imetelstat. I think the bozos at Geron just kept screwing up and, to me, are not sensitive enough for the Imetelstat patent expiry in 2025. Hope Tefferi remains optimistic and makes the board get rid of Huh and Scarlett. Finally, everybody was concerned that the shares will sink after RS; but, they held up well and even went up a bit. That is indicative of optimism.
"Maximize the worth"?!!!! You must be kidding?!!!! The two have virtually killed the company, reducing it to a just one-product company and have failed so far to earn any noticeable respect from the FDA. And, OPC1 trial approval by the FDA clearly shows that these two bozos were out of their mind to dispose off the stem cell assets dirt cheap!! Note that your dreams do not make the future; it's the history full of facts that counts.
What is the weightage of Tefferi's disturbing dislike and public criticism of Jakafi inhibitors? Is it all ignored by the FDA? What does Tefferi has to say about Pacritinib?
Excellent summary; and, it's a realistic assessment. Thanks for that End!
My conclusion is that Geron board needs to pursue accountability investigation for both Huh and Scarlett. With these two at the helm, I only see more frustrations for retail shareholders. And, they have done a lousy job at adding to shareholder value if you keep in mind the fact that neither of the two had any input in development of Imetelstat; and, despite putting all their eggs in the Imetelstat basket, they kept screwing up its licensing process. I will single out these two bozos who squeezed hefty compensation from this resource-poor company and not justifying their remuneration. We, the shareholders, not only lost our hundreds of millions in investment for stemcells patents and rights; but have lost potential share value(which was considered to be in 40s and 50s down to 10s) through their repeated screw ups of solid-tumor and hematolgical trials for Imetelstat, the only product the company owns now These bozos now are primarily riding on the success brought about by Tefferi. And, yet, to my dismay, many on this board love them!! What an irony!!
My vote is unfavorable and it should be known to all who have been reading my posts for at least the last several weeks I have also given my views in the posts occasionally. Please treat those as sincere. Thanks.
Guys, if she is what she claimed, she certainly will respond to these posts. None of you have to speak for or against her!! Just be patient and wait in case she is away to respond.
that Scarlett and Huh are the right guys to take this company to glory? Please vote through Up Thumb for favorable vote and vice versa for your unfavorable vote. If you have a favorable vote, please do not hesitate to give your reasons briefly. Please be honest and take this survey seriously and to the benefit of all who visit this board Thanks.
Perhaps Irish got frustrated with Geron and sold off her Geron holdings in case the two bozos sell the company and its BT product cheap through their WS buddies!!
There are idiots in the FDA and also it's full of agents of vested interests. If Jakafi with all its side effects much more severe than those found with use of Imetelstat for MF is allowed rampant use by this agency, you should know who controls the FDA. In our capitalistic system, shouldn't power of money rule?!!!! The problem with Geron is that it's headed by two bozos who act like a misguided missile.
Why did you miss the offer from Maine who wanted to sell all his holdings in ASTY because he trusts Scarlett-Huh team so much he hated stem-cells and West-Okarma team!!!
Wall Street has more confidence in West-Okarma team than inept Huh-Scarlett team!!!
It's all reflective of inability and ineptness of Scarlett and Huh to lead Geron.!! I do not see any other reason!
We're in a world where there is cut-throat competition. I am sure if Imetelstat brought CRs and PRs, as shown by none other than the world-famous and respected outfit like Mayo, there will be at least a few large pharmas who will be coming to the help. Scarlett and Huh are just two frustratingly inept guys who can't bring that out quickly!!!